Decline in Pfizer efficiency rate in country leading vaccination drive

Israel is reporting that Pfizer Covid-19 vaccine is highly effective at preventing individuals from developing severe disease

Although the jab is less effective at preventing people from getting coronavirus in the first place, hospitalisations have fallen dramatically in recent weeks.

According to government data out of Israel, it continues to provide a strong shield against severe Covid-19.

As the Delta variant spreads through Israel, government data has found that the Pfizer jab’s effectiveness at preventing severe disease stands at 93 percent.

Figures between May second and June fifth show the vaccine had a 94 percent efficiency rate, whereas five days later after restrictions eased that went to 64 percent.

The Delta variant first emerged in India and has been spreading rapidly around the globe as governments rush to increase their vaccination rollouts or halt further easing of restrictions.

Pfizer says the current evidence suggests the jab “will continue to protect against these variants.”

Israel is known to have one of the world’s best vaccination rollout programs, with around 57 percent of the population now fully vaccinated.

Israel has recorded a steep drop in the efficiency rate of the Pfizer vaccine in preventing coronavirus infections.

About 57 per cent of the population is now fully vaccinated, but many new Covid-19 cases are among vaccinated people.

Pfizer Chief Executive Officer has said people will likely need a third dose within 12 months of getting fully protected.